Marcus Lind

8.0k total citations · 3 hit papers
135 papers, 5.1k citations indexed

About

Marcus Lind is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Marcus Lind has authored 135 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Endocrinology, Diabetes and Metabolism, 37 papers in Surgery and 31 papers in Genetics. Recurrent topics in Marcus Lind's work include Diabetes Management and Research (96 papers), Diabetes Treatment and Management (78 papers) and Pancreatic function and diabetes (32 papers). Marcus Lind is often cited by papers focused on Diabetes Management and Research (96 papers), Diabetes Treatment and Management (78 papers) and Pancreatic function and diabetes (32 papers). Marcus Lind collaborates with scholars based in Sweden, United States and Germany. Marcus Lind's co-authors include Ann‐Marie Svensson, Annika Rosengren, Sofia Dahlqvist, Aldina Pivodic, Soffia Guðbjörnsdóttir, Hans Wedel, Mikhail Kosiborod, Mark A. Clements, Arndís F. Ólafsdóttir and Björn Eliasson and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Marcus Lind

126 papers receiving 5.0k citations

Hit Papers

Excess Mortality among Pe... 2014 2026 2018 2022 2015 2014 2017 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Excess Mortality among Persons with Type 2 Diabetes
    2015 721 citations Annika Rosengren, Ann‐Marie Svensson et al. profile →
  2. Glycemic Control and Excess Mortality in Type 1 Diabetes
    2014 673 citations Marcus Lind, Ann‐Marie Svensson et al. profile →
  3. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections
    2017 529 citations Marcus Lind, William H. Polonsky et al. JAMA profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Marcus Lind 3.9k 1.6k 1.4k 1.0k 567 135 5.1k
Ann‐Marie Svensson 4.1k 1.1× 1.6k 1.0× 1.3k 0.9× 1.5k 1.5× 808 1.4× 127 6.0k
Valma Harjutsalo 2.1k 0.5× 923 0.6× 1.3k 0.9× 639 0.6× 376 0.7× 137 3.9k
Stefan Franzén 2.8k 0.7× 1.2k 0.7× 390 0.3× 1.3k 1.2× 727 1.3× 97 4.8k
Marc Evans 3.6k 0.9× 991 0.6× 419 0.3× 875 0.8× 1.2k 2.1× 183 5.5k
Eugene Manley 5.3k 1.4× 1.3k 0.8× 639 0.4× 959 0.9× 1.4k 2.4× 13 7.2k
Thomas Danne 3.6k 0.9× 2.5k 1.5× 2.2k 1.5× 461 0.4× 285 0.5× 192 4.8k
Michael J. Nissen 2.9k 0.7× 1.1k 0.7× 750 0.5× 1.1k 1.1× 852 1.5× 64 6.0k
Aldina Pivodic 1.6k 0.4× 843 0.5× 644 0.5× 840 0.8× 292 0.5× 119 3.1k
Jane L. Chiang 2.6k 0.7× 1.3k 0.8× 1.4k 1.0× 300 0.3× 432 0.8× 15 4.0k
Donna Wright 5.8k 1.5× 1.4k 0.8× 715 0.5× 990 1.0× 1.4k 2.5× 9 7.9k

Countries citing papers authored by Marcus Lind

Since Specialization
Citations

This map shows the geographic impact of Marcus Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Lind more than expected).

Fields of papers citing papers by Marcus Lind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Lind. The network helps show where Marcus Lind may publish in the future.

Co-authorship network of co-authors of Marcus Lind

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus Lind. A scholar is included among the top collaborators of Marcus Lind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus Lind. Marcus Lind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Friman, Ola, Marcus Lind, Ragnar Thobaben, et al.. (2025). Accuracy of Glucose Trends by Subcutaneous Continuous Monitoring vs Intermittent Arterial Measurements in Critically Ill Patients. Journal of Diabetes Science and Technology. 580968046–580968046.
2.
3.
Glynn, L. E., Marcus Lind, Tomas Andersson, et al.. (2024). Trends in Survival After First Myocardial Infarction in People With Diabetes. Journal of the American Heart Association. 13(10). e034741–e034741. 2 indexed citations
4.
Imberg, Henrik, Irl B. Hirsch, Erik Schwarcz, et al.. (2024). Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia. 67(8). 1517–1526. 8 indexed citations
5.
Friman, Ola, Marcus Lind, P Zetterqvist, et al.. (2024). Performance of Subcutaneous Continuous Glucose Monitoring in Adult Critically Ill Patients Receiving Vasopressor Therapy. Diabetes Technology & Therapeutics. 26(10). 763–772. 8 indexed citations
6.
Imberg, Henrik, et al.. (2024). Effects, Safety, and Treatment Experience of Advanced Hybrid Closed-Loop Systems in Clinical Practice Among Adults Living With Type 1 Diabetes. Journal of Diabetes Science and Technology. 19(6). 1598–1607. 7 indexed citations
7.
Rhee, Connie M., Roma Gianchandani, David Kerr, et al.. (2024). Consensus Report on the Use of Continuous Glucose Monitoring in Chronic Kidney Disease and Diabetes. Journal of Diabetes Science and Technology. 19(1). 217–245. 7 indexed citations
8.
Sandström, Tatiana Zverkova, Annika Rosengren, Penelope Trimpou, et al.. (2023). Mortality in Patients With Primary Aldosteronism: A Swedish Nationwide Study. Hypertension. 80(12). 2601–2610. 9 indexed citations
9.
Ólafsdóttir, Arndís F., et al.. (2023). The effect of carbohydrate intake on glycaemic control in individuals with type 1 diabetes: a randomised, open-label, crossover trial. The Lancet Regional Health - Europe. 37. 100799–100799. 4 indexed citations
10.
Lind, Marcus, Mikael Andersson, Anders Oldner, et al.. (2023). Glycaemic control and sepsis risk in adults with type 1 diabetes. Diabetes Obesity and Metabolism. 25(7). 1942–1949. 6 indexed citations
11.
González‐Pérez, Antonio, David Vizcaya, María Eugenia Sáez, Marcus Lind, & Luis A. Garcı́a Rodrı́guez. (2023). Cardiovascular and renal outcomes among patients with type 2 diabetes using SGLT2 inhibitors added to metformin: a population-based cohort study from the UK. BMJ Open Diabetes Research & Care. 11(1). e003072–e003072. 7 indexed citations
12.
Ólafsdóttir, Arndís F., et al.. (2023). Design of a randomized cross-over study evaluating effects of carbohydrate intake on glycemic control in persons with type 1 diabetes. Frontiers in Nutrition. 10. 1114317–1114317. 1 indexed citations
13.
14.
Adiels, Martin, Lena Björck, Martin Lindgren, et al.. (2022). Body mass index in adolescence, risk of type 2 diabetes and associated complications: A nationwide cohort study of men. EClinicalMedicine. 46. 101356–101356. 26 indexed citations
15.
Lind, Marcus, Henrik Imberg, Ruth L. Coleman, Olle Nerman, & Rury R. Holman. (2021). Historical HbA1c Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88. Diabetes Care. 44(10). 2231–2237. 75 indexed citations
16.
Darsalia, Vladimer, Marcus Lind, Ann‐Marie Svensson, et al.. (2021). Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study. Cardiovascular Diabetology. 20(1). 202–202. 97 indexed citations
17.
Hirsch, Irl B., et al.. (2021). Characteristics of Continuous Glucose Monitoring Metrics in Persons with Type 1 and Type 2 Diabetes Treated with Multiple Daily Insulin Injections. Diabetes Technology & Therapeutics. 23(6). 425–433. 3 indexed citations
18.
19.
Lind, Marcus, William H. Polonsky, Irl B. Hirsch, et al.. (2017). Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections. JAMA. 317(4). 379–379. 529 indexed citations breakdown →
20.
Lind, Marcus, Anders Odén, Martin Fahlén, & Björn Eliasson. (2009). The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables. PLoS ONE. 4(2). e4412–e4412. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ann‐Marie Svensson Breakdown of academic impact, for papers by Valma Harjutsalo Breakdown of academic impact, for papers by Stefan Franzén Breakdown of academic impact, for papers by Marc Evans Breakdown of academic impact, for papers by Eugene Manley Breakdown of academic impact, for papers by Thomas Danne Breakdown of academic impact, for papers by Michael J. Nissen Breakdown of academic impact, for papers by Aldina Pivodic Breakdown of academic impact, for papers by Jane L. Chiang Breakdown of academic impact, for papers by Donna Wright
Rankless by CCL
2026